April 16, 2011Open Access

Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract Infection

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Lactin-V after treatment for cystitis is associated with a reduction in recurrent UTI. Larger efficacy trials of this novel preventive method for recurrent UTI are warranted. CLINICAL TRIALS REGISTRATION. NCT00305227.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Stapleton et al. (Sat,) studied this question.

synapsesocial.com/papers/69dcaf0598c6111533e536eb https://doi.org/https://doi.org/10.1093/cid/cir183

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Use of Lactobacillus probiotics for bacterial genitourinary infections in women: A review2008 · 239 citations
2The Bacterial Flora of the Vaginal Vestibule, Urethra and Vagina in Premenopausal Women with Recurrent Urinary Tract Infections1981 · 69 citations
3Selection of Vaginal H2O2-Generating Lactobacillus Species for Probiotic Use1999 · 115 citations
4Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth.1988 · 304 citations
5Treatment of uncomplicated urinary tract infection in non-pregnant women1972 · 159 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo